Show simple item record

dc.contributor.authorTuset, Een_US
dc.contributor.authorMatutes, Een_US
dc.contributor.authorBrito-Babapulle, Ven_US
dc.contributor.authorMorilla, Ren_US
dc.contributor.authorCatovsky, Den_US
dc.date.accessioned2018-09-26T08:36:06Z
dc.identifier6en_US
dc.identifier.citationLEUKEMIA & LYMPHOMA, 42 pp. 1379 - 1383en_US
dc.identifier.issn1042-8194en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2870
dc.identifier.doi10.3109/10428190109097766en_US
dc.description.abstractT-cell prolymphocytic leukaemia (T-PLL) is an aggressive disease often resistant to conventional chemotherapy. Long lasting remissions with the monoclonal antibody CAMPATH-1H (anti-CD52) have been documented. We describe two unusual T-PLL patients treated successfully first with CAMPATH-1H in whom, at the time of relapse, the cells underwent a phenotypic switch with loss of CD52 expression. In one of them, cytogenetic analysis demonstrated the same chromosome abnormalities in the cells at diagnosis and relapse. The reasons for the immunophenotypic changes are unknown but it is likely that loss of CD52 antigen expression contributed to the resistance to CAMPATH-1H in one of the patients when re-treated.en_US
dc.format.extent1379 - 1383en_US
dc.titleImmunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemiaen_US
dc.typeJournal Article
dcterms.dateAccepted2009-07-01en_US
rioxxterms.versionofrecord10.3109/10428190109097766en_US
rioxxterms.licenseref.startdate2009-07-01en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfLEUKEMIA & LYMPHOMAen_US
pubs.notesunique-id: ISI:000173558700026en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Molecular Haematology (including Cytogenetics Group and Cell Markers)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular Haematology (including Cytogenetics Group and Cell Markers)
pubs.volume42en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMolecular Haematology (including Cytogenetics Group and Cell Markers)en_US
dc.contributor.icrauthorMatutes, Estellaen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record